Measuring the burden of arboviral diseases: The spectrum of morbidity and mortality from four prevalent infections

Population Health Metrics

Volumn 9, Issue , 2011, Pages

  LaBeaud, A Desirée ^a,b   Bashir, Fatima ^a   King, Charles H ^b  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA SET; DISABILITY; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; GLOBAL PERSPECTIVE; HEALTH IMPACT; LITERATURE REVIEW; MORBIDITY; MORTALITY; VIRAL DISEASE;

ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL TRIAL; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; EPIDEMIC; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RISK; JAPANESE ENCEPHALITIS; MORBIDITY; MORTALITY; MULTICENTER STUDY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; QUALITY OF LIFE; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SPECTRUM; THREAT; VIRUS INFECTION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

ARBOVIRUS; CHIKUNGUNYA VIRUS; JAPANESE ENCEPHALITIS VIRUS; RIFT VALLEY FEVER VIRUS; YELLOW FEVER VIRUS;

EID: 78650965909     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/1478-7954-9-1     Document Type: Article

References (104)

1. CDC Viral Hemorrhagic Fevers Fact Sheet. accessed March 29, 2010., http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm
2. CDC Arboviral Encephalitides Fact Sheet. accessed July 12, 2010., http://www.cdc.gov/ncidod/dvbid/Arbor/index.htm
3. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008, 371:500-509. 10.1016/S0140-6736(08)60238-X, 18262042.
4. Sang RC, Dunster LM. The growing threat of arbovirus transmission and outbreaks in Kenya: a review. East Afr Med J 2001, 78:655-661.
5. Gubler D. The emergence of epidemic dengue fever and dengue hemorrhagic fever in the Americas: a case of failed public health policy. Rev Panam Salud Publica 2005, 17:221-224. 10.1590/S1020-49892005000400001, 15969972.
6. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11:480-496. 88892, 9665979.
7. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002, 33:330-342. 10.1016/S0188-4409(02)00378-8, 12234522.
8. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002, 10:100-103. 10.1016/S0966-842X(01)02288-0, 11827812.
9. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995, 1:55-57. 10.3201/eid0102.950204, 2626838, 8903160.
10. Gubler DJ, Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res 1999, 53:35-70. full_text, 10582094.
11. Lundstrom JO. Mosquito-borne viruses in western Europe: a review. J Vector Ecol 1999, 24:1-39.
12. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004, 10:S98-109. 10.1038/nm1144, 15577938.
13. Mackenzie JS, Johansen CA, Ritchie SA, van den Hurk AF, Hall RA. Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol Immunol 2002, 267:49-73.
14. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344:1807-1814. 10.1056/NEJM200106143442401, 11407341.
15. W.H.O. Dengue and dengue haemorrhagic fever fact sheet. No. 117 March 2009. , http://www.who.int/mediacentre/factsheets/fs117/en/
16. LaBeaud AD. Why arboviruses can be neglected tropical diseases. PLoS Negl Trop Dis 2008, 2:e247. 10.1371/journal.pntd.0000247, 2427179, 18575597.
17. LaBeaud AD, Lisgaris MV, King CH, Mandalakas AM. Pediatric West Nile virus infection: neurologic disease presentations during the 2002 epidemic in Cuyahoga County, Ohio. Pediatr Infect Dis J 2006, 25:751-753. 10.1097/01.inf.0000227830.73271.65, 16874181.
18. Robin S, Ramful D, Le Seach F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 2008, 23:1028-1035. 10.1177/0883073808314151, 18287573.
19. Balkhy HH, Schreiber JR. Severe La Crosse encephalitis with significant neurologic sequelae. Pediatr Infect Dis J 2000, 19:77-80. 10.1097/00006454-200001000-00016, 10643856.
20. Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, Bergloff P, Crosby RD. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 2006, 43:723-730. 10.1086/506939, 16912946.
21. Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, Layton M, Nash D. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004, 10:1405-1411.
22. Ou AC, Ratard RC. One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana. J La State Med Soc 2005, 157:42-46.
23. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003, 290:511-515. 10.1001/jama.290.4.511, 12876094.
24. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Pape J, Biggerstaff BJ, Petersen LR. West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis 2006, 12:514-516.
25. Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007, 44:1617-1624. 10.1086/518281, 17516407.
26. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 2004, 141:360-365.
27. LaBeaud AD, Muchiri EM, Ndzovu M, Mwanje MT, Muiruri S, Peters CJ, King CH. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg Infect Dis 2008, 14:1240-1246. 10.3201/eid1408.080082, 2600406, 18680647.
28. Siam AL, Gharbawi KF, Meegan JM. Ocular complications of Rift Valley fever. J Egypt Public Health Assoc 1978, 53:185-186.
29. Siam AL, Meegan J. Ocular disease resulting from infection with Rift Valley fever virus. Trans R Soc Trop Med Hyg 1980, 74:539. 10.1016/0035-9203(80)90074-7, 7192443.
30. Siam AL, Meegan JM, Gharbawi KF. Rift Valley fever ocular manifestation: observations during the 1977 epidemic in the Arab Republic of Egypt. British Journal of Ophthalmology 1980, 64:366-374. 10.1136/bjo.64.5.366, 1043698, 7192158.
31. Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, Saadi R, Ahmed N. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 2005, 112:313-318. 10.1016/j.ophtha.2004.09.018, 15691569.
32. Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, Hazmi A, Abdullah M, Abbo H, Elamin A, et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 2003, 36:245-252. 10.1086/345671, 12539063.
33. Anninger W, Lubow M. Visual loss with West Nile virus infection: a wider spectrum of a "new" disease. Clin Infect Dis 2004, 38:e55-56. 10.1086/382884, 15034847.
34. Anninger WV, Lomeo MD, Dingle J, Epstein AD, Lubow M. West Nile virus-associated optic neuritis and chorioretinitis. Am J Ophthalmol 2003, 136:1183-1185. 10.1016/S0002-9394(03)00738-4, 14644244.
35. Eidsness RB, Stockl F, Colleaux KM. West Nile chorioretinitis. Can J Ophthalmol 2005, 40:721-724.
36. Hershberger VS, Augsburger JJ, Hutchins RK, Miller SA, Horwitz JA, Bergmann M. Chorioretinal lesions in nonfatal cases of West Nile virus infection. Ophthalmology 2003, 110:1732-1736. 10.1016/S0161-6420(03)00720-6, 13129870.
37. Khairallah M, Ben Yahia S, Ladjimi A, Zeghidi H, Ben Romdhane F, Besbes L, Zaouali S, Messaoud R. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology 2004, 111:2065-2070. 10.1016/j.ophtha.2004.03.032, 15522373.
38. Khairallah M, Yahia SB, Letaief M, Attia S, Kahloun R, Jelliti B, Zaouali S, Messaoud R. A prospective evaluation of factors associated with chorioretinitis in patients with West Nile virus infection. Ocul Immunol Inflamm 2007, 15:435-439. 10.1080/09273940701798488, 18085487.
39. Koevary SB. Ocular involvement in patients infected by the West Nile virus. Optometry 2005, 76:609-612.
40. Bacsal KE, Chee SP, Cheng CL, Flores JV. Dengue-associated maculopathy. Arch Ophthalmol 2007, 125:501-510. 10.1001/archopht.125.4.501, 17420370.
41. Gupta A, Srinivasan R, Setia S, Soundravally R, Pandian DG. Uveitis following dengue fever. Eye (Lond) 2009, 23:873-876.
42. Kapoor HK, Bhai S, John M, Xavier J. Ocular manifestations of dengue fever in an East Indian epidemic. Can J Ophthalmol 2006, 41:741-746. 10.3129/I06-069, 17224957.
43. Lim WK, Mathur R, Koh A, Yeoh R, Chee SP. Ocular manifestations of dengue fever. Ophthalmology 2004, 111:2057-2064. 10.1016/j.ophtha.2004.03.038, 15522372.
44. Mehta S, Jiandani P. Ocular features of dengue septic shock (DSS). J Assoc Physicians India 2006, 54:866.
45. Nah G, Tan M, Teoh S, Chong CH. Maculopathy associated with Dengue fever in a military pilot. Aviat Space Environ Med 2007, 78:1064-1067. 10.3357/ASEM.2138.2007, 18018440.
46. Seet RC, Quek AM, Lim EC. Symptoms and risk factors of ocular complications following dengue infection. J Clin Virol 2007, 38:101-105. 10.1016/j.jcv.2006.11.002, 17142099.
47. Su DH, Bacsal K, Chee SP, Flores JV, Lim WK, Cheng BC, Jap AH. Prevalence of dengue maculopathy in patients hospitalized for dengue fever. Ophthalmology 2007, 114:1743-1747. 10.1016/j.ophtha.2007.03.054, 17561258.
48. Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R, Sathe P. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am J Ophthalmol 2007, 144:552-556. 10.1016/j.ajo.2007.06.002, 17692276.
49. Mittal A, Mittal S, Bharati MJ, Ramakrishnan R, Saravanan S, Sathe PS. Optic neuritis associated with chikungunya virus infection in South India. Arch Ophthalmol 2007, 125:1381-1386. 10.1001/archopht.125.10.1381, 17923547.
50. Mittal A, Mittal S, Bharathi JM, Ramakrishnan R, Sathe PS. Uveitis during outbreak of Chikungunya fever. Ophthalmology 2007, 114:1798. 10.1016/j.ophtha.2007.03.045, 17822999.
51. Mahendradas P, Ranganna SK, Shetty R, Balu R, Narayana KM, Babu RB, Shetty BK. Ocular manifestations associated with chikungunya. Ophthalmology 2008, 115:287-291. 10.1016/j.ophtha.2007.03.085, 17631967.
52. Yim R, Posfay-Barbe KM, Nolt D, Fatula G, Wald ER. Spectrum of clinical manifestations of West Nile virus infection in children. Pediatrics 2004, 114:1673-1675. 10.1542/peds.2004-0491, 15574633.
53. Bjorn G. Victims of West Nile virus face long-term health problems. Nat Med 2008, 14:700. 10.1038/nm0708-700b, 18607355.
54. Murray KO, Baraniuk S, Resnick M, Arafat R, Kilborn C, Shallenberger R, York TL, Martinez D, Malkoff M, Elgawley N, et al. Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004. Vector Borne Zoonotic Dis 2008, 8:167-174. 10.1089/vbz.2007.0109, 18399781.
55. Gould EA, Solomon T, Mackenzie JS. Does antiviral therapy have a role in the control of Japanese encephalitis?. Antiviral Res 2008, 78:140-149. 10.1016/j.antiviral.2007.10.005, 18053589.
56. Solomon T, Kneen R, Dung NM, Khanh VC, Thuy TT, Ha DQ, Day NP, Nisalak A, Vaughn DW, White NJ. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998, 351:1094-1097. 10.1016/S0140-6736(97)07509-0, 9660579.
57. Marimoutou C, Vivier E, Simon F. Long-lasting overmorbidity and impaired quality of life 30 months after chikungunya infection: Comparative cohort of French gendarmes exposed to chikungunya in 2006 in Reunion Island [abstract 376]. American Society of Tropical Medicine and Hygiene 59th Annual Meeting; Atlanta, Georgia. Am J Trop Med Hyg 2010, 109.
58. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007, 1:e114. 10.1371/journal.pntd.0000114, 2100367, 18060077.
59. Murray CJL, Lopez AD. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. 1996, Cambridge MA: Harvard School of Public Health/World Bank.
60. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global Burden of Disease and Risk Factors. 2006, Washington DC: World Bank.
61. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, . (Eds) Disease Control Priorities in Developing Countries 2/e. 2006, New York: Oxford University Press, (Eds).
62. Khairallah M, Ben Yahia S, Attia S, Zaouali S, Ladjimi A, Messaoud R. Linear pattern of West Nile virus-associated chorioretinitis is related to retinal nerve fibres organization. Eye (Lond) 2007, 21:952-955.
63. Sanders EJ, Marfin AA, Tukei PM, Kuria G, Ademba G, Agata NN, Ouma JO, Cropp CB, Karabatsos N, Reiter P, et al. First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Am J Trop Med Hyg 1998, 59:644-649.
64. Lowry PW, Truong DH, Hinh LD, Ladinsky JL, Karabatsos N, Cropp CB, Martin D, Gubler DJ. Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995. Am J Trop Med Hyg 1998, 58:324-329.
65. Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, Wengling C, Michault A, Paganin F. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007, 44:1401-1407. 10.1086/517537, 17479933.
66. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009, 49:942-948. 10.1086/605496, 19663604.
67. Riou O, Philippe B, Jouan A, Coulibaly I, Mondo M, Digoutte JP. [Neurologic and neurosensory forms of Rift Valley fever in Mauritania]. Bull Soc Pathol Exot Filiales 1989, 82:605-610.
68. Kahlon SS, Peters CJ, Leduc J, Muchiri EM, Muiruri S, Njenga MK, Breiman RF, Clinton White A, King CH. Severe Rift Valley fever may present with a characteristic clinical syndrome. Am J Trop Med Hyg 2010, 82:371-375. 10.4269/ajtmh.2010.09-0669, 20207858.
69. Murray CJ. Rethinking DALYs. The Global Burden of Disease 1996, 1-98. Cambridge MA: Harvard School of Public Health/World Bank, Murray CJ, Lopez AD.
70. Anderson RM, May RM. Infectious Diseases of Humans. Dynamics and Control. 1991, New York: Oxford University Press.
71. Mudur G. Failure to control mosquitoes has led to two fever epidemics in India. BMJ 2006, 333:773. 10.1136/bmj.333.7572.773-c, 1602027, 17038726.
72. Fischer M, Lindsey N, Staples JE, Hills S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010, 59:1-27.
73. Mandalakas AM, Kippes C, Sedransk J, Kile JR, Garg A, McLeod J, Berry RL, Marfin AA. West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis 2005, 11:1774-1777.
74. Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, Muchiri E, Dunster L, Henderson A, Khan AS, Swanepoel R, et al. An outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98. Emerging Infectious Diseases 2002, 8:138-144. 10.3201/eid0802.010023, 11897064.
75. Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks--the globalization of vectorborne diseases. N Engl J Med 2007, 356:769-771. 10.1056/NEJMp078013, 17314335.
76. Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, Muchiri E, Dunster L, Henderson A, Khan AS, Swanepoel R, et al. An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis 2002, 8:138-144. 10.3201/eid0802.010023, 2732454, 11897064.
77. Kari K, Liu W, Gautama K, Mammen MP, Clemens JD, Nisalak A, Subrata K, Kim HK, Xu ZY. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 2006, 4:8. 10.1186/1741-7015-4-8, 1481508, 16603053.
78. Mutebi JP, Barrett AD. The epidemiology of yellow fever in Africa. Microbes Infect 2002, 4:1459-1468. 10.1016/S1286-4579(02)00028-X, 12475636.
79. Monath TP. Yellow fever: an update. Lancet Infect Dis 2001, 1:11-20. 10.1016/S1473-3099(01)00016-0, 11871403.
80. Gould LH, Osman MS, Farnon EC, Griffith KS, Godsey MS, Karch S, Mulenda B, El Kholy A, Grandesso F, de Radigues X, et al. An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005. Trans R Soc Trop Med Hyg 2008, 102:1247-1254. 10.1016/j.trstmh.2008.04.014, 18502458.
81. Ribeiro M, Antunes CM. [Yellow fever: study of an outbreak]. Rev Soc Bras Med Trop 2009, 42:523-531.
82. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT. Japanese encephalitis. J Neurol Neurosurg Psychiatry 2000, 68:405-415. 10.1136/jnnp.68.4.405, 1736874, 10727474.
83. Hossain MJ, Gurley ES, Montgomery S, Petersen L, Sejvar J, Fischer M, Panella A, Powers AM, Nahar N, Uddin AK, et al. Hospital-based surveillance for Japanese encephalitis at four sites in Bangladesh, 2003-2005. Am J Trop Med Hyg 2010, 82:344-349. 10.4269/ajtmh.2010.09-0125, 20134015.
84. Tandale BV, Sathe PS, Arankalle VA, Wadia RS, Kulkarni R, Shah SV, Shah SK, Sheth JK, Sudeep AB, Tripathy AS, Mishra AC. Systemic involvements and fatalities during chikungunya epidemic in India, 2006. J Clin Virol 2009, 46:145-149. 10.1016/j.jcv.2009.06.027, 19640780.
85. Soumahoro MK, Gerardin P, Boelle PY, Perrau J, Fianu A, Pouchot J, Malvy D, Flahault A, Favier F, Hanslik T. Impact of chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One 2009, 4:e7800. 10.1371/journal.pone.0007800, 2771894, 19911058.
86. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on Reunion Island. Clin Infect Dis 2008, 47:469-475. 10.1086/590003, 18611153.
87. de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness. BMC Infect Dis 2010, 10:31. 10.1186/1471-2334-10-31, 2833164, 20170492.
88. Seyler T, Hutin Y, Ramanchandran V, Ramakrishnan R, Manickam P, Murhekar M. Estimating the burden of disease and the economic cost attributable to chikungunya, Andhra Pradesh, India, 2005-2006. Trans R Soc Trop Med Hyg 2010, 104:133-138. 10.1016/j.trstmh.2009.07.014, 19709705.
89. Meegan JM, Hoogstraal H, Moussa MI. An epizootic of Rift Valley fever in Egypt in 1977. Vet Rec 1979, 105:124-125. 10.1136/vr.105.6.124, 505918.
90. Peters CJ, Liu CT, Anderson GW, Morrill JC, Jahrling PB. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis 1989, 11(Suppl 4):S743-749.
91. Njenga MK, Paweska J, Wanjala R, Rao CY, Weiner M, Omballa V, Luman ET, Mutonga D, Sharif S, Panning M, et al. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J Clin Microbiol 2009, 47:1166-1171. 10.1128/JCM.01905-08, 2668310, 19171680.
92. Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo J, Mutonga D, Rao CY, Lederman E, Schnabel DC, Paweska JT, et al. Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hyg 2010, 83(Suppl 2):14-21.
93. Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003, 9:788-793.
94. Shears P. Emerging and reemerging infections in Africa: the need for improved laboratory services and disease surveillance. Microbes Infect 2000, 2:489-495. 10.1016/S1286-4579(00)00309-9, 10865194.
95. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG, Lewallen S, Liomba NG, Molyneux ME. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004, 10:143-145. 10.1038/nm986, 14745442.
96. Vazquez-Prokopec GM, Stoddard ST, Paz-Soldan V, Morrison AC, Elder JP, Kochel TJ, Scott TW, Kitron U. Usefulness of commercially available GPS data-loggers for tracking human movement and exposure to dengue virus. Int J Health Geogr 2009, 8:68. 10.1186/1476-072X-8-68, 2792221, 19948034.
97. Winter-Nelson A, Rich KM. Mad cows and sick birds: financing international responses to animal disease in developing countries. Development Policy Review 2008, 26:211-226.
98. Hales S, Weinstein P, Woodward A. Public health impacts of global climate change. Rev Environ Health 1997, 12:191-199.
99. Githeko AK, Lindsay SW, Confalonieri UE, Patz JA. Climate change and vector-borne diseases: a regional analysis. Bull World Health Organ 2000, 78:1136-1147. 2560843, 11019462.
100. Patz JA, Lindsay SW. New challenges, new tools: the impact of climate change on infectious diseases. Curr Opin Microbiol 1999, 2:445-451. 10.1016/S1369-5274(99)80078-2, 10490352.
101. Shope R. Global climate change and infectious diseases. Environ Health Perspect 1991, 96:171-174. 10.2307/3431227, 1568225, 1820262.
102. Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007, 88:2363-2377. 10.1099/vir.0.82858-0, 17698645.
103. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006, 3:e263. 10.1371/journal.pmed.0030263, 1463904, 16700631.
104. LaBeaud AD, Ochiai Y, Peters CJ, Muchiri EM, King CH. Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. Am J Trop Med Hyg 2007, 76:795-800. 2367216, 17488893.